PERLICH IRENE (Principal Accounting Officer) reported 1 transaction at NGM BIOPHARMACEUTICALS INC
Review the transaction codes below to understand the nature of each event.
Filed: 1/18/2024ACC: 0001415889-24-001543
Officer· Principal Accounting Officer
Since Sep 2023
-1.02K
Net shares
Net seller
$1.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.02K
Price / share
$1.34
Trade value
$1.37K
% of position
10.3%
1/16/2024
10K→8.97K
Total
Net shares
−1.02K
Net value
-$1.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/16/2024 | F · Tax Withholding | −1.02K | $1.34 | $1.37K | 10.3% | 10K | 8.97K |
| Total | −1.02K | -$1.37K | ||||||
Derivative Transactions0
No derivative transactions reported